Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 14, 2022; 28(30): 4019-4043
Published online Aug 14, 2022. doi: 10.3748/wjg.v28.i30.4019
Table 3 Differences in lymph node processing methods and upstage rates of previous reports
Ref.
Subject (patients)
OSNA method
Harvested LN, n
Harvested LN, median
Dividing method of LN
Pathological staining
Measured LN by OSNA, n
Measured LN by OSNA, median
Upstage rate (pStage I and II)
Yamamoto et al[16]Stage 0, I (85)cOSNA434N/AaFourb; 4 mm over diameter of LNHE and IHC3854.516.5% (2/16)
Güller et al[12]Stage I, II, III (22)cOSNA31330 (16–60)Fourb; 3 mm over diameter of LNHE and IHC 5613 (6–24)15.3% (2/13)
Croner et al[14]Stage I, II (103)cOSNAN/AaN/AaCenterc; 6 mm over halfd; 4 mm to 6 mm diameter of LNHE159414 (1–46)25.2% (26/103)
Vogelaar et al[15]Stage I, II (128)cOSNAN/AaN/AaFourb; 10 mm over halfd; 10 or less than 10 mm diameter of LNHE and IHC317Mean 15.3 (4–40)20.2% (20/90)
Yamamoto et al[17]Stage I, II, III (204)cOSNA432419 (3–25)Halfd HE19258 (2–25)17.6% (13/74)
Aldecoa et al[133]Stage I, II (149) cOSNA248315CentercHE19401251% (76/149)
Rakislova et al[125] Stage I, II, III (188)cOSNA, pOSNAcOSNA 1828, pOSNA 1992cOSNA 17 (13-22), pOSNA 20.5 (17-27)CentercHEcOSNA 1757, pOSNA 1449cOSNA 13 (10-18), pOSNA 18 (13-25)cOSNA 55.4% (51/92), pOSNA 20.7% (16/77)
Brito et al[126] Stage I, II (59)cOSNA104613 (9-19)Centerc; 5 mm over halfd; 4 or less diameter of LNHE75312 (7-16)28.8% (17/59)
Itabashi et al[18]Stage I, II, III (195)cOSNANot shown19 (1-75)Halfd; 4 mm over diameter of LNHENot shown8 (2-25)15.7% (11/70) in stage II patients
Tani et al[33]Stage II, IIIA (92)pOSNA223624.3 (5–66)Halfd; 4 mm over diameter of LNHE6366.9 (1–35)9.1% (6/66)